Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877095 · ClinicalTrials.gov registry record · Phase 1
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
A Phase 1 study of Acute Heart Failure, sponsored by Adrian Hernandez.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 5
- Study locations
NCT02877095: Completed Phase 1 study of Acute Heart Failure, sponsored by Adrian Hernandez.
NCT02877095 is a Phase 1 study of Acute Heart Failure that has completed, run by Adrian Hernandez. The registered enrollment target is 40 participants, below the 1,448-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877095, a Phase 1 study of Acute Heart Failure, has completed, sponsored by Adrian Hernandez.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Pilot study is designed to evaluate the overall safety and feasibility of a strategy based on subcutaneous delivery of furosemide. It will be used to inform the subsequent evaluation phase of the study (separate protocol). The primary objective of the study is to determine if a strategy of a novel subcutaneous delivery of furosemide is safe and feasible in patients with acute heart failure.
Primary Outcome
The analysis of data from the Pilot Phase will be primarily descriptive in nature and there will be no formal hypothesis testing. Number of patients with events will be reported.
Conditions Studied
Interventions
- DRUG Furosemide
Study Locations (5)
Georgia
- Emory University Hospital - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
North Carolina
- Duke University Medical Center - Durham
Ohio
- Metro Health System - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-12-19 |
| Est. Completion | 2017-11-07 |
| Phase | Phase 1 |
What the finished NCT02877095 record still lists
NCT02877095 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,448-participant average among 8 other Acute Heart Failure trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Acute Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Furosemide is the first listed.
NCT02877095 lists 5 locations in 5 states (Georgia, Massachusetts, Minnesota).
Frequently Asked Questions
What is clinical trial NCT02877095 about?
NCT02877095 is a clinical study titled "Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot". The Pilot study is designed to evaluate the overall safety and feasibility of a strategy based on subcutaneous delivery of furosemide. It will be used to inform the subsequent evaluation phase of the study (separate protocol). The primary objective of the study is to determine if a strategy of a nov...
What is the current status of trial NCT02877095?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2016-12-19. Estimated completion is 2017-11-07.
What conditions does trial NCT02877095 study?
This clinical trial studies the following conditions: Acute Heart Failure.
What interventions are being tested in trial NCT02877095?
The interventions under investigation include: Furosemide (DRUG).
Who is sponsoring clinical trial NCT02877095?
This trial is sponsored by Adrian Hernandez, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02877095 being conducted?
This trial has 5 study locations across Georgia, Massachusetts, Minnesota, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02877095's enrollment target sits among peer trials
40 9th of 8 the lowest of 8 other Acute Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RECRUITING · Phase 3
-
Improving Diagnostic Accuracy for Acute Heart Failure
ACTIVE NOT RECRUITING
-
Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)
ACTIVE NOT RECRUITING · Phase 2
-
An Observational Study of the Functional Capacity of Heart Failure
COMPLETED · NA
-
Tezosentan in Acute Heart Failure
COMPLETED · Phase 3
-
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI